These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22468818)

  • 21. Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers.
    Lee YC; Wang HP; Wang CP; Ko JY; Lee JM; Chiu HM; Lin JT; Yamashita S; Oka D; Watanabe N; Matsuda Y; Ushijima T; Wu MS
    Cancer Prev Res (Phila); 2011 Dec; 4(12):1982-92. PubMed ID: 21952583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is gene expression profiling of head and neck cancers ready for the clinic?
    Ziober AF; D'Alessandro L; Ziober BL
    Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers of squamous cell carcinoma of the head and neck.
    Kim J; Shin DM
    Histol Histopathol; 1997 Jan; 12(1):205-18. PubMed ID: 9046056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene profiling in squamous cell carcinoma of the head and neck.
    Akervall J
    Cancer Metastasis Rev; 2005 Jan; 24(1):87-94. PubMed ID: 15785874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular markers of radiation effectiveness in head and neck squamous cell carcinoma.
    Koch W; Sidransky D
    Semin Radiat Oncol; 2004 Apr; 14(2):130-8. PubMed ID: 15095259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
    Lim Y; Sun CX; Tran P; Punyadeera C
    Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Almadori G; Bussu F; Paludetti G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
    Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
    Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.
    Koturbash I; Beland FA; Pogribny IP
    Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New molecular diagnostic methods in head and neck cancer.
    Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
    Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
    Yarbrough WG
    Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
    Wang L; Rodriguez M; Kim ES; Xu Y; Bekele N; El-Naggar AK; Hong WK; Mao L; Oh YW
    Int J Oncol; 2004 Oct; 25(4):993-9. PubMed ID: 15375549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathology of head-and-neck cancer.
    Kim MM; Califano JA
    Int J Cancer; 2004 Nov; 112(4):545-53. PubMed ID: 15382034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review.
    Juodzbalys G; Kasradze D; Cicciù M; Sudeikis A; Banys L; Galindo-Moreno P; Guobis Z
    Cancer Biomark; 2016; 17(4):487-502. PubMed ID: 27802200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on molecular diagnostic tests in head and neck cancer.
    Palka KT; Slebos RJ; Chung CH
    Semin Oncol; 2008 Jun; 35(3):198-210. PubMed ID: 18544435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant epigenetic modifications in radiation-resistant head and neck cancers.
    Lin HY; Huang TH; Chan MW
    Methods Mol Biol; 2015; 1238():321-32. PubMed ID: 25421668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetics of head and neck cancer.
    Sidransky D
    Curr Opin Oncol; 1995 May; 7(3):229-33. PubMed ID: 7654824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.